Trial intelligence / Profile preview

Modafinil for Cancer-Related Fatigue

NCT00178373Phase 2Completed

Sponsor
University of Rochester
Start
May 2004
Primary completion
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of modafinil in cancer-related fatigue (CRF), sponsored by University of Rochester. Started May 2004; status: completed.

02

Drugs

modafinil
03

Conditions

cancer-related fatigue (CRF)

Beyond the preview

Go deeper on NCT00178373.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00178373.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call